Detalhe da pesquisa
1.
Real-world use of multigene signatures in early breast cancer: differences to clinical trials.
Breast Cancer Res Treat
; 205(1): 39-48, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38265569
2.
Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer.
Br J Cancer
; 127(10): 1787-1792, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35995934
3.
A Remote Monitoring System to Optimize the Home Management of Oral Anticancer Therapies (ONCO-TreC): Prospective Training-Validation Trial.
J Med Internet Res
; 24(1): e27349, 2022 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35080505
4.
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study.
Lancet Oncol
; 22(12): 1669-1680, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34741822
5.
Prevalence and Clinical Impact of SARS-CoV-2 Silent Carriers Among Actively Treated Patients with Cancer During the COVID-19 Pandemic.
Oncologist
; 26(4): 341-347, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33355953
6.
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer.
N Engl J Med
; 379(2): 122-137, 2018 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29863451
7.
Subcutaneous trastuzumab with pertuzumab and docetaxel in HER2-positive metastatic breast cancer: Final analysis of MetaPHER, a phase IIIb single-arm safety study.
Breast Cancer Res Treat
; 187(2): 467-476, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33748921
8.
Thrombotic biomarkers for risk prediction of malignant disease recurrence in patients with early stage breast cancer.
Haematologica
; 105(6): 1704-1711, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31558668
9.
Recent advances in the management of chemotherapy-induced neutropenia: biosimilar granulocyte colony-stimulating factor use in Italy.
Future Oncol
; 16(14): 891-897, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32329365
10.
Endocrine therapy for hormone receptor-positive, HER2-negative metastatic breast cancer: extending endocrine sensitivity.
Future Oncol
; 16(5): 129-145, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31849236
11.
The spectrum of BRCA1 and BRCA2 pathogenic sequence variants in Middle Eastern, North African, and South European countries.
Hum Mutat
; 40(11): e1-e23, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31209999
12.
Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in the TREnd trial.
Breast Cancer Res
; 21(1): 71, 2019 05 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31142370
13.
Prognostic impact of regression in patients with primary cutaneous melanoma >1 mm in thickness.
J Am Acad Dermatol
; 80(1): 99-105.e5, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30447951
14.
Cobimetinib in malignant melanoma: how to MEK an impact on long-term survival.
Future Oncol
; 15(9): 967-977, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30638071
15.
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.
Lancet Oncol
; 19(10): 1385-1393, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30196031
16.
Adjuvant exemestane with ovarian suppression in premenopausal breast cancer.
N Engl J Med
; 371(2): 107-18, 2014 Jul 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24881463
17.
Breast-cancer risk in families with mutations in PALB2.
N Engl J Med
; 371(6): 497-506, 2014 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-25099575
18.
Mitotic rate correlates with sentinel lymph node status and outcome in cutaneous melanoma greater than 1 millimeter in thickness: A multi-institutional study of 1524 cases.
J Am Acad Dermatol
; 76(2): 264-273.e2, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27847125
19.
Haplotype analyses of the c.1027C>T and c.2167_2168delAT recurrent truncating mutations in the breast cancer-predisposing gene PALB2.
Breast Cancer Res Treat
; 160(1): 121-129, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27624329
20.
Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials.
Lancet Oncol
; 16(7): 848-58, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26092816